MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 1, 2007; DOI: 10.1124/mol.107.035840


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.035840v1
72/2/259    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, M.
Right arrow Articles by Tseng, G.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, M.
Right arrow Articles by Tseng, G.-N.


Received for publication March 9, 2007.
Revised April 27, 2007.
Accepted for publication April 30, 2007.

APETx1 from sea anemone Anthopleura elegantissima is a gating modifier peptide toxin of the human ether-a-go-go-related (hERG) potassium channel

Mei Zhang 1, Xian-Sheng Liu 1, Sylvie Diochot 2, Michel Lazdunski 2, Gea-Ny Tseng 1*

1 Virginia Commonwealth University 2 CNRS UMR 6097

* Address correspondence to: E-mail: gtseng{at}vcu.edu

Abstract

We studied the mechanism of action and the binding site of APETx1, a peptide toxin purified from sea anemone, on the hERG channel. Similar to the effects of gating modifier toxins (hanatoxin and SGTx) on the Kv2.1 channel, APETx1 shifts the voltage-dependence of hERG activation in the positive direction and suppresses its current amplitudes elicited by strong depolarizing pulses that maximally activate the channels. The APETx1 binding site is distinctly different from that of a pore-blocking peptide toxin, BeKm-1. Mutations in the S3b region of hERG have dramatic impact on the responsiveness to APETx1: G514C potentiates while E518C abolishes APETx1 effect. Restoring the negative charge at position 518 (MTSES modification of 518C) partially restores APETx1 responsiveness, supporting an electrostatic interaction between E518 and APETx1. Among the 3 hERG isoforms, hERG1 and hERG3 are equally responsive to APETx1 while hERG2 is insensitive. The key feature appears to be an arginine residue uniquely present at the 514-equivalent position in hERG2, where the other two isoforms possess a glycine. Our data show that APETx1 is a gating modifier toxin of the hERG channel, and its binding site shares characteristics with those of gating modifier toxin binding sites on other Kv channels.


Key words: Ion channel regulation, Structure determinations





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics